Home » Newsletters » BioWorld Science

BioWorld Science

Feb. 24, 2021

View Archived Issues

Classifying variants of unknown significance

Amyris announces promising preclinical data for its novel COVID-19 RNA vaccine platform

Novel COVID-19 MATE program candidate effectively neutralizes multiple strains of SARS-CoV-2

Curocell receives IND clearance in Korea for its CD19 CAR-T therapy, CRC-01

FDA clears IND for phase III trial of OT-101 for myopia

Targeting PI3K-driven HER2 expression in colorectal cancer stem cells

Topline data from phase III BRIGHT study of pegunigalsidase alfa for Fabry Disease

Inovio initiates dosing in phase Ib study of INO-4500 vaccine against Lassa Fever in West Africa

Pentaglobin to be evaluated in immunomodulatory therapy arm of ACOVACT COVID-19 study

Researchers patent new PROTACs

BeiGene discloses new PROTACs for cancer

Jinan University synthesizes new EGFR inhibitors

Medshine Discovery synthesizes FGFR and VEGFR dual inhibitors

The Titan Leading Med Tech discovers new GLP-1 receptor agonists

Elicio receives IND clearance for phase I/II trial of ELI-002

New phase I study evaluates AbFero's SP-420 to treat transfusional iron overload

Akeso reports phase III interim data on penpulimab with chemotherapy for squamous NSCLC

Amicus Therapeutics presents preclinical data for Fabry disease therapeutic AT-GTX-701

Activation of CARD8 inflammasome triggers pyroptosis of HIV-1-infected cells

China NMPA accepts IND for JS-111

Calpain-2 inhibition as a promising approach for treating seizure-induced neuropathology

Australian researchers identify potential treatment for fatal brain cancer in children

NeuroRx reports interim data from phase IIb/III trial of aviptadil in COVID-19

FDA clears IND for pilot study of NT-17 in progressive multifocal leukoencephalopathy

Nanoform reports further data from phase I study of Nanoformed piroxicam

Opthea prepares to begin pivotal phase III trials of OPT-302 in wet AMD